Cosmos Health Reaffirms 2029 Guidance
COSM•Company reaffirms 2029 outlook
- Cosmos Health: A company transformed — 2026 year-to-date
- 2029 guidance reaffirmed: $200.60 million revenue, $71.20 million gross profit, $31 million net income, $44.20 million adjusted EBITDA
